Kwok J M, Miller T D, Christian T F, Hodge D O, Gibbons R J
Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA.
JAMA. 1999 Sep 15;282(11):1047-53. doi: 10.1001/jama.282.11.1047.
Exercise testing of patients with ST-T abnormalities on the resting electrocardiogram (ECG) is problematic because in the presence of pre-existing ST-T abnormalities, the exercise test is less specific for the diagnosis of coronary artery disease. The prognostic capability of the Duke treadmill score in patients with ST-T abnormalities vs those with normal findings on resting ECG has, to our knowledge, not been evaluated.
To compare the prognostic accuracy of the Duke treadmill score in patients with nonspecific ST-T abnormalities vs those with normal results on resting ECG.
Inception cohort study with 7 years of follow-up.
Nuclear cardiology laboratory of a US referral center.
All symptomatic patients who underwent exercise thallium testing between 1989 and 1991,939 of whom had nonspecific ST-T abnormalities and 1466 of whom had normal findings on resting ECG. Exclusion criteria included congenital, valvular, or cardiomyopathic heart disease; prior coronary artery revascularization; resting ECG with secondary ST-T abnormalities; or missing data.
Rates of overall mortality and cardiac death for subjects classified by Duke treadmill score risk group.
For the end point cardiac death, 7-year survival in the study population in the low-, intermediate-, and high-risk groups was 97%, 92%, and 76%, respectively (P<.001). Compared with the control group, the study group had lower 7-year survival (94% vs 98%; P<.001), fewer low-risk patients (426 [45%] vs 811 [55%]; P<.001) with worse 7-year survival (97% vs 99%; P= .008), and more high-risk patients (49 [5%] vs 34 [2%];P<.001) with a nonsignificant trend toward worse 7-year survival (76% vs 93%; P= .36).
The Duke treadmill score can effectively risk-stratify patients with ST-T abnormalities on the resting ECG. In classified risk categories, patients with ST-T abnormalities have a worse prognosis than those with normal results on resting ECG.
静息心电图(ECG)有ST-T异常的患者进行运动试验存在问题,因为在已有ST-T异常的情况下,运动试验对冠心病诊断的特异性较低。据我们所知,静息ECG有ST-T异常的患者与静息ECG结果正常的患者相比,杜克运动平板评分的预后能力尚未得到评估。
比较静息ECG有非特异性ST-T异常的患者与静息ECG结果正常的患者中杜克运动平板评分的预后准确性。
开展有7年随访的起始队列研究。
美国一家转诊中心的核心脏病学实验室。
1989年至1991年间接受运动铊试验的所有有症状患者,其中939例有非特异性ST-T异常,1466例静息ECG结果正常。排除标准包括先天性、瓣膜性或心肌病性心脏病;既往冠状动脉血运重建;伴有继发性ST-T异常的静息ECG;或数据缺失。
按杜克运动平板评分风险组分类的受试者的总死亡率和心源性死亡率。
对于心源性死亡这一终点,低、中、高风险组研究人群的7年生存率分别为97%、92%和76%(P<0.001)。与对照组相比,研究组的7年生存率较低(94%对98%;P<0.001),低风险患者较少(426例[45%]对811例[55%];P<0.001),其7年生存率较差(97%对99%;P=0.008),高风险患者较多(49例[5%]对34例[2%];P<0.001),7年生存率有变差的非显著趋势(76%对93%;P=0.36)。
杜克运动平板评分可有效对静息ECG有ST-T异常的患者进行危险分层。在分类的风险类别中,静息ECG有ST-T异常的患者比静息ECG结果正常的患者预后更差。